Effects of three kinds of anti-amyloid-β drugs on clinical, biomarker, neuroimaging outcomes and safety indexes: A systematic review and meta-analysis of phase II/III clinical trials in Alzheimer’s disease
Diyang Lyu, Xuanxin Lyu, Li Huang, Boyan Fang
Topics & Concepts
MedicineMeta-analysisClinical trialCochrane LibraryInternal medicineRandomized controlled trialCognitionCognitive declineDiseaseSystematic reviewDementiaBiomarkerOncologyMEDLINEPsychiatryPolitical scienceChemistryLawBiochemistryAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchMedicinal Plants and Neuroprotection